Skip to content

OCULUX

Active Risk: very low
Private limited companyfounded 2023active for 3 yearsWitte Torenwal 9, 3960 Bree, BelgiumKBO/BCE: BE 0803.897.002
Summary

OCULUX has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €150,000. Its solvency ranks better than 15% of 3,011 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Financials · financial year 2025, abbreviated format

Turnover
≈ €1.2m
Estimated: probably between €780,000 and €1.8m
Total assets
€1.4m▼ 15.9%
2024 · €1.7m
Net result
Not included in this filing
Working capital
-€117,735▼ 87.4%
2024 · -€62,835
Trend over the years

2024 to 2025, 2 financial years

The operating result falls in 2025; 2025 is 42% below 2024.

What the company sold each financial year and what was left of it. A loss stands below the zero line.

Operating result€0.03m 2025

Use the arrow keys on the chart for the figures per year.

Sector: the middle half of NACE 86, Human health activities: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30. Dashed line: the median. Available for Equity, Total assets, Working capital, Solvency, Current ratio, Staff (FTE).

Every figure with its change against the financial year before
favourable unfavourable
Line20242025
Operating result€0.05m-€0.03m▼ 41.6%
Equity€0.2mwithin the sector's middle half-€0.2mwithin the sector's middle half=
Total assets€1.7mwithin the sector's middle half-€1.4mwithin the sector's middle half▼ 15.9%
Debt€1.5m-€1.2m▼ 17.4%
Working capital-€0.06mbelow the sector's middle half--€0.1mbelow the sector's middle half▼ 87.4%
Solvency9.1%below the sector's middle half-10.8%below the sector's middle half▲ 1.7pp
Current ratio0.94below the sector's middle half-0.88below the sector's middle half▼ 0.06
Staff (FTE)6.1within the sector's middle half-7.5above the sector's middle half▲ 23.0%
above within below the middle half of NACE 86, Human health activities: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30.
Turnover and EBIT margin not published: the abbreviated format does not require them. The turnover shown is an estimate from the gross margin.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.4m
Fixed assets €562,236 ▼ 16.5%
Current assets €831,546 ▼ 15.4%
Equity and liabilities €1.4m
Equity €150,000 =
Debt €1.2m ▼ 17.4%
Debt's share of the balance-sheet total falls from 90.9% to 89.2%. Debt is lower.
Key figures and ratios
2025 value · change against 2024
EBITDA
€185,469▼
2024 · €272,880
Debt to equity
8.29▼
2024 · 10.04
Interest coverage
6.16▲
2024 · 5.26
Debt ≤ 1 year
€949,280▼
2024 · €1.0m
Debt > 1 year
€288,995▼
2024 · €460,489
Income taxes
€1,400▼
2024 · €2,046
Staff costs
€409,081▼
2024 · €506,341
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 41 lines
Balance sheet Code20242025
Assets
Total assets20/58€1.7m€1.4m▼
Fixed assets21/28€0.7m€0.6m▼
Intangible fixed assets21€0.4m€0.3m▼
Tangible fixed assets22/27€0.3m€0.2m▼
Land and buildings22-€0.02m
Plant, machinery and equipment23€0.3m€0.2m▼
Furniture and vehicles24€0.002m€0.01m▲
Leasing and similar rights25€0.02m€0.006m▼
Current assets29/58€1.0m€0.8m▼
Amounts receivable within one year40/41€0.02m€0.02m▲
Trade receivables40€0.02m€0.02m▲
Cash at bank and in hand54/58€0.9m€0.8m▼
Deferred charges and accrued income490/1€0.06m€0.06m▼
Equity and liabilities
Total equity and liabilities10/49€1.7m€1.4m▼
Equity10/15€0.2m€0.2m=
Contributions10/11€0.2m€0.2m=
Amounts payable17/49€1.5m€1.2m▼
Amounts payable after more than one year17€0.5m€0.3m▼
Financial debts170/4€0.5m€0.3m▼
Amounts payable within one year42/48€1.0m€0.9m▼
Current portion of amounts payable after more than one year42€0.2m€0.2m▲
Trade debts44€0.02m€0.05m▲
Suppliers440/4€0.02m€0.05m▲
Taxes, remuneration and social security45€0.002m€0.001m▼
Taxes450/3€0.002m€0.001m▼
Other amounts payable47/48€0.9m€0.7m▼
Accrued charges and deferred income492/3€228€0.006m▲
Income statement Code20242025
Remuneration, social security and pensions62€0.5m€0.4m▼
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€0.2m€0.2m▼
Other operating charges640/8€0.003m€0.002m▼
Non-recurring operating charges66A-€463
Gross operating margin9900€0.8m€0.6m▼
Operating profit (loss)9901€0.05m€0.03m▼
Financial income75/76B€335€151▼
Recurring financial income75€335€151▼
Financial charges65/66B€0.05m€0.03m▼
Recurring financial charges65€0.05m€0.03m▼
Non-recurring financial charges66B€80-
Profit (loss) for the period before taxes9903€0.002m€0.001m▼
Income taxes67/77€0.002m€0.001m▼
Social balance sheet
Average headcount (FTE)90876.17.5▲

The notes to these accounts (12 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line20242025Change
Remuneration, social security and pensions62€506,341€409,081▼ 19.2%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€219,208€154,103▼ 29.7%
Other operating charges640/8€2,898€2,094▼ 27.8%
Non-recurring operating charges66A-€463-
Gross operating margin9900€782,119€597,107▼ 23.7%
Operating profit (loss)9901€53,672€31,366▼ 41.6%
Financial income75/76B€335€151▼ 54.8%
Recurring financial income75€335€151▼ 54.8%
Financial charges65/66B€51,961€30,118▼ 42.0%
Recurring financial charges65€51,881€30,118▼ 41.9%
Non-recurring financial charges66B€80--
Profit (loss) for the period before taxes9903€2,046€1,400▼ 31.6%
Income taxes67/77€2,046€1,400▼ 31.6%
Line20242025Change
Assets
Total assets20/58€1.7m€1.4m▼ 15.9%
Fixed assets21/28€0.7m€0.6m▼ 16.5%
Intangible fixed assets21€0.4m€0.3m▼ 16.6%
Tangible fixed assets22/27€0.3m€0.2m▼ 16.4%
Land and buildings22-€0.02m-
Plant, machinery and equipment23€0.3m€0.2m▼ 25.7%
Furniture and vehicles24€0.002m€0.01m▲ 473%
Leasing and similar rights25€0.02m€0.006m▼ 62.7%
Current assets29/58€1.0m€0.8m▼ 15.4%
Amounts receivable within one year40/41€0.02m€0.02m▲ 7.9%
Trade receivables40€0.02m€0.02m▲ 7.9%
Cash at bank and in hand54/58€0.9m€0.8m▼ 16.3%
Deferred charges and accrued income490/1€0.06m€0.06m▼ 9.7%
Equity and liabilities
Total equity and liabilities10/49€1.7m€1.4m▼ 15.9%
Equity10/15€0.2m€0.2m=
Contributions10/11€0.2m€0.2m=
Amounts payable17/49€1.5m€1.2m▼ 17.4%
Amounts payable after more than one year17€0.5m€0.3m▼ 37.2%
Financial debts170/4€0.5m€0.3m▼ 37.2%
Amounts payable within one year42/48€1.0m€0.9m▼ 9.2%
Current portion of amounts payable after more than one year42€0.2m€0.2m▲ 2.6%
Trade debts44€0.02m€0.05m▲ 170%
Suppliers440/4€0.02m€0.05m▲ 170%
Taxes, remuneration and social security45€0.002m€0.001m▼ 56.4%
Taxes450/3€0.002m€0.001m▼ 56.4%
Other amounts payable47/48€0.9m€0.7m▼ 15.6%
Accrued charges and deferred income492/3€228€0.006m▲ 24×
Line20242025Change
+ Depreciation and write-downs630€219,208€154,103▼ 29.7%
Operating cash flow (approximation)€219,208€154,103▼ 29.7%
Investment in fixed assets (approximation)--€42,787-
Change in cash--€146,465-

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Filings with the National Bank (2)
Financial year Type Filed Reference
31-12-2025 abbreviated format 23-06-2026 2026-00185647
31-12-2024 abbreviated format 24-07-2025 2025-00300466

Similar companies · same sector, comparable size

Of the 16,579 active companies whose main activity is specialist medical practice (NACE 86220), figures are known for 8,122. 6,822 are within a factor 10 of this equity. These 5 are the closest to it. See the whole sector

Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.